跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VEKLURY remdesivir 100 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VEKLURY remdesivir 100 mg powder for injection vial
Approved
STANDARD
VEKLURY remdesivir 100 mg powder for injection vial
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f7712f31fe7c63d2
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
f7712f31fe7c63d2
Product Name
VEKLURY remdesivir 100 mg powder for injection vial
Artg Id
338419
Artg Name
VEKLURY remdesivir 100 mg powder for injection vial
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2020-07-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01929-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01927-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f7712f31fe7c63d2
Type
Standard
Back to TGA Approvals